American Journal of Obstetrics & Gynecology
Volume 200, Issue 4 , Pages 365.e1-365.e8 , April 2009

Preventing type 2 diabetes: public health implications for women with a history of gestational diabetes mellitus

  • Lucinda J. England, MD, MSPH

      Affiliations

    • Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, GA
    • ,
  • Patricia M. Dietz, DrPH, MPH

      Affiliations

    • Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, GA
    • ,
  • Terry Njoroge, MPH

      Affiliations

    • Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, GA
    • ,
  • William M. Callaghan, MD, MPH

      Affiliations

    • Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, GA
    • ,
  • Carol Bruce, BSN, MPH

      Affiliations

    • Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, GA
    • ,
  • Rebecca M. Buus, PhD

      Affiliations

    • Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, GA
    • ,
  • David F. Williamson, PhD

      Affiliations

    • Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA

Received 25 January 2008 ,Revised 8 April 2008 ,Accepted 11 June 2008.

References 

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053
  2. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med. 2006;12:62–66
  3. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431
  4. Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007;334:299
  5. Oldroyd JC, Unwin NC, White M, Mathers JC, Alberti KG. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Res Clin Pract. 2006;72:117–127
  6. Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30:753–759
  7. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359:2072–2077
  8. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 2002;51:2796–2803
  9. Buchanan TA. Pancreatic beta-cell loss and preservation in type 2 diabetes. Clin Ther. 2003;25(Suppl 2):B32–B46
  10. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403
  11. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance (The Da Qing IGT and Diabetes Study). Diabetes Care. 1997;20:537–544
  12. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289–297
  13. Xiang AH, Peters RK, Kjos SL, et al. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes. 2006;55:517–522
  14. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155–161
  15. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350
  16. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115:485–491
  17. Engelgau MM, Colagiuri S, Ramachandran A, Borch-Johnsen K, Narayan KM. Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions. Diabetes Technol Ther. 2004;6:874–882
  18. US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: Recommendations and rationale. Ann Intern Med. 2003;138:212–214
  19. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am. 2007;34:173–199
  20. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA. 2005;294:2751–2757
  21. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115:485–491
  22. Russell MA, Phipps MG, Olson CL, Welch HG, Carpenter MW. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol. 2006;108:1456–1462
  23. Kim C, Tabaei BP, Burke R, et al. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health. 2006;96:1643–1648
  24. Smirnakis KV, Chasan-Taber L, Wolf M, Markenson G, Ecker JL, Thadhani R. Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol. 2005;106:1297–1303
  25. Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL. Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol. 2002;186:751–756
  26. Conway DL, Langer O. Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol. 1999;181:610–614
  27. Albareda M. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care. 2003;26:1199–1205
  28. Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care. 2007;30:878–883
  29. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–1868
  30. Centers for Disease Control and Prevention, National Center for Health Statistics, Division of Health Interview Statistics. http://www.cdc.gov/diabetes/statistics/incidence/fig2.htmAccessed Sept. 4, 2007
  31. Oldfield MD, Donley P, Walwyn L, Scudamore I, Gregory R. Long term prognosis of women with gestational diabetes in a multiethnic population. Postgrad Med J. 2007;83:426–430
  32. Kousta E, Lawrence NJ, Godsland IF, et al. Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol (Oxf). 2003;59:289–297
  33. Kousta E, Efstathiadou Z, Lawrence NJ, et al. The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes. Diabetologia. 2006;49:36–40
  34. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes (Utility of early postpartum glucose tolerance testing). Diabetes. 1995;44:586–591
  35. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med. 2004;21:103–113
  36. Hanson U. Increased molar proinsulin-to-insulin ratio in women with previous gestational diabetes does not predict later impairment of glucose tolerance. Diabetes Care. 1996;19:17–20
  37. Aberg AE. Predictive factors of developing diabetes mellitus in women with gestational diabetes. Acta Obstet Gynecol Scand. 2002;81:11–16
  38. Benjamin E, Winters D, Mayfield J, Gohdes D. Diabetes in pregnancy in Zuni Indian women (Prevalence and subsequent development of clinical diabetes after gestational diabetes). Diabetes Care. 1993;16:1231–1235
  39. O'Sullivan JB. Diabetes mellitus after GDM. Diabetes. 1991;40(Suppl 2):131–135
  40. Damm P. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol. 1992;167:607–616
  41. Santaguida PL, Balion C, Hunt D, et al. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess (Summ). 2005;128:1–11
  42. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Gestational diabetes. Obstet Gynecol. 2001;98:525–538
  43. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):S88–S90
  44. Standards of medical care in diabetes—2007. Diabetes Care. 2007;30(Suppl 1):S4–S41
  45. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30(Suppl 2):S251–S260
  46. Buchanan TA. (How) can we prevent type 2 diabetes?. Diabetes. 2007;56:1502–1507
  47. Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA. Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes. 2006;55:1074–1079
  48. Festa A, Williams K, D'Agostino R, Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes. 2006;55:1114–1120
  49. Goldfine AB, Bouche C, Parker RA, et al. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. PNAS. 2003;100:2724–2729
  50. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 357: Primary and preventive care: periodic assessments. Obstet Gynecol. 2006;108:1615–1622
  51. Gabbe SG, Gregory RP, Power ML, Williams SB, Schulkin J. Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol. 2004;103:1229–1234
  52. Dinh DT, Musser J, Bayliss PM. Does postpartum diabetic testing occur in gestational diabetes?. Prim Care Update. 2003;10:182–185
  53. Greenberg LR. Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol. 1995;86:97–101
  54. Dacus JV, Meyer NL, Muram D, Stilson R, Phipps P, Sibai BM. Gestational diabetes: postpartum glucose tolerance testing. Am J Obstet Gynecol. 1994;171:927–931
  55. Kaufmann RC, Smith T, Bochantin T, Khardori R, Evans MS, Steahly L. Failure to obtain follow-up testing for gestational diabetic patients in a rural population. Obstet Gynecol. 1999;93(5 Pt 1):734–737
  56. Ratner RE. Prevention of type 2 diabetes in women with previous gestational diabetes. Diabetes Care. 2007;30(Suppl 2):S242–S245
  57. Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368:1096–1105
  58. Schwartz AV. Thiazolidinediones: new evidence of bone loss. J Clin Endocrinol Metab. 2007;92:1232–1234
  59. Schwartz AV. Thiazolidinedione therapy gets complicated: is bone loss the price of improved insulin resistance?. Diabetes Care. 2007;30:1670–1671
  60. Schwartz AV. Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab. 2006;91:3349–3354
  61. Solomon DH. Cardiovascular risk and the thiazolidinediones: deja vu all over again?. JAMA. 2007;298:1216–1218
  62. Haffner SM. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes. 1990;39:283–288
  63. Polley BA, Wing RR, Sims CJ. Randomized controlled trial to prevent excessive weight gain in pregnant women. Int J Obes Relat Metab Disord. 2002;26:1494–1502
  64. Leermakers EA, Anglin K, Wing RR. Reducing postpartum weight retention through a correspondence intervention. Int J Obes Relat Metab Disord. 1998;22:1103–1109
  65. O'Toole ML, Sawicki MA, Artal R. Structured diet and physical activity prevent postpartum weight retention. J Womens Health. 2003;12:991–998
  66. Gabbe S, Hill L, Schmidt L, Schulkin J. Management of diabetes by obstetrician-gynecologists. Obstet Gynecol. 1998;91(5 Pt 1):643–647
  67. Cheung NW, Byth K. Population health significance of gestational diabetes. Diabetes Care. 2003;26:2005–2009
  68. Kim C, Herman WH, Vijan S. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care. 2007;30:1102–1106

 Cite this article as: England LJ, Dietz PM, Njoroge T, et al. Preventing type 2 diabetes: public health implications for women with a history of gestational diabetes mellitus. Am J Obstet Gynecol 2009;200:365.e1-365.e8.

 Reprints not available from the authors.

 This study was supported by the Centers for Disease Control and Prevention, Atlanta, GA.

 The findings and conclusions of this report are those of the authors and do not necessarily represent those of the Centers for Disease Control and Prevention.

PII: S0002-9378(08)00642-X

doi: 10.1016/j.ajog.2008.06.031

American Journal of Obstetrics & Gynecology
Volume 200, Issue 4 , Pages 365.e1-365.e8 , April 2009

Article Tools